Sema4 secures a deal to acquire GeneDx, capturing $200M in private investment

The deal between Stamford, Connecticut-based Sema4 and GeneDx’s parent, Miami-based OPKO Health, was fortified with a $200 million private placement from growth and life sciences investors, including Pfizer.